Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » News & Views » Treatment News

Special Reports

Rallying Behind HIV Vaccine Research

The Mother of All Battles

Face and Butt, Heal Thyselves

» More

Most Talked About

An HIV Doc's Dilemma (38)

Virtual Prevention: Fighting HIV Online (26)

HIV-Positive Man Sentenced to 35 Years for Spitting (20)

Face and Butt, Heal Thyselves (15)

Lambda Legal Responds to HIV Spitting Conviction (15)

Most Popular Lessons

Herpes Simplex Virus

Syphilis & Neurosyphilis

Shingles

The HIV Life Cycle

Human Papilloma Virus (HPV)

10 Years Ago In POZ

More Treatment News

May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
February 2006

emailrssprint

February 19, 2008

Starting Treatment With Higher CD4s Cuts Death Rate

People who start antiretroviral treatment with CD4 counts above 350 have the lowest risk of disease progression and death compared with people who start at CD4 counts below 350, say the authors of a study published in the February 1 issue of the Journal of Acquired Immune Deficiency Syndromes (JAIDS) and reported by AIDSmap. The study lends further support to a trend, marked by recent changes to U.S. HIV treatment guidelines, suggesting that antiretroviral therapy should be started earlier than had been previously recommended.

A research team headed by Ángeles Jaén, MD, PhD, from the Centre d’Estudis Epidemiològics sobre ITS/VIH/SIDA de Catalunya in Badalona, Spain, reviewed the medical records from a large group of people living with HIV, called the PICSCIS cohort, being cared for at 10 hospitals throughout Spain. Nearly 7,000 people living with HIV were followed between 1998 and December 2004.

Dr. Jaén’s team closely evaluated records for 2,035 people who had started a three-drug combination antiretroviral regimen and who had their CD4 counts measured within six months before starting treatment. The patients were then split into three groups: those who waited to start antiretroviral therapy until their CD4 count had dropped below 200; those who started treatment at a CD4 count between 200 and 350; and those who started treatment with a CD4 count greater than 350.

A total of 148 patients progressed to AIDS or died over an average of roughly three years of follow-up. Using a relatively simple comparative analysis, the authors found that a number of factors were associated with an increased risk of disease progression. These included starting treatment with a CD4 count of less than 200, having a high viral load, being of older age, being an injection-drug user and being coinfected with hepatitis C (HCV).

After controlling for a number of factors, Jaén’s team found that people who started treatment with a CD4 count between 200 and 350 had a lower risk of disease progression than people who waited to start treatment until their CD4 count dropped below 200. Similar results from other studies recently inspired the United States and Europe to revise their HIV treatment guidelines, which now recommend that antiretroviral treatment be started in people with CD4 counts below 350. Jaén’s team asserts that the results of their study support those guidelines’ changes.

An additional finding, that the risk of disease progression in people who started treatment at CD4 counts above 350 was lower than in people who started treatment at CD4 counts between 200 and 350, lends credibility to the belief that even moderate levels of immune suppression may be harmful, and raises the question of whether starting treatment even earlier may be warranted.

NEW! Scroll down to comment on this story.

emailrssprint

Name:

(2-50 characters)

Email:

(will not show)

City:

(optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

  comments 1 - 4 (of 4 total)    

JADE, , 2008-03-16 16:27:49
I believe aids is only a health situation who must be handle by the person as to be a personal daily basis. aim a hiv person for 18 yrs I start Med on 2008 I feel great , better at never SO be positive be your self

MICHAEL GIANNINI, Charlottesville, 2008-03-08 21:02:35
been on Atripla since dec 06 viral load gone from 255,000 to les then 50 C4 count from 327 to 773 main concern med cost so much , not sure how much longer I can afford it

don, seattle, 2008-02-24 00:30:45
I started meds when i was bouncing around between 350-400 for a year or so, but I was so exhausted and depressed with a lack of energy and GI tract issues I felt the need to start. Within a month it was amazing the difference. Within a year my counts were over 600 and undectable, with no side effects. I wished I had started sooner. They say HIV attacks in the gut first, and in my case I certainly felt my system was being damaged long before "350". Who came up with that number anyway?

phillip, rochester, 2008-02-23 03:53:39
what about my situation is this ... im first year poz and viral load of 98 and cd4 counts of 1050..so if i wer to start to progress quickly should i start meds sooner like 500 i get checked quarterly ? and should i start now while its so low a viral load?

comments 1 - 4 (of 4 total)    


[Go to top]

Get Started
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Talk to Us
Weekly Poll
Question: Do you suffer from allergies?
Yes
No

Monthly Poll
Question: Why are women being diagnosed so late that they have progressed to AIDS by the time of their diagnosis?
Women are too busy taking care of other family members
Doctors aren't testing
Doctors are unaware that a woman's symptoms can differ from a man's
Fear of HIV stigma
Denial
Women's lack of empowerment

Surveys
How do you see America's place in the global AIDS epidemic?

Tell us your political opinions on HIV/AIDS

more surveys  
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy